Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples